valanafusp alpha: Clinical Trials

2 trials of valanafusp alpha, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 22Completed 2

Follow valanafusp alpha: new trials by email Literature Review of valanafusp alpha trials Research Report on valanafusp alpha

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Extension Study Evaluating Long Term Safety and Activity of AGT-181 in Children With MPS I
AGT-181 - Mucopolysaccharidosis I
Phase 1 / Phase 2CompletedArmaGen, Inc192016-10-012023-03-15
Safety and Dose Ranging Study of Human Insulin Receptor MAb-IDUA Fusion Protein in Adults and Children With MPS I
AGT-181 - Mucopolysaccharidosis I
Phase 1 / Phase 2CompletedArmaGen, Inc212015-10-012023-03-15

Conditions studied

Mucopolysaccharidosis I (2)

Sponsors

ArmaGen, Inc (2)

Countries

Brazil (2)

Top investigators

Patrice P Rioux, MD PhD (2)

Results publications

PMID 29976218